Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8466 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8457 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8395 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8232 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8225 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8103 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8072 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8025 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7919 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7901 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7895 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7886 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7882 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7861 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7853 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7853 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7853 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7848 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7841 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7829 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7816 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7812 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7811 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7797 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7791 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7765 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7744 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7727 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7725 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7683 |
Intermediate Similarity |
NPD6799 |
Approved |
0.767 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7658 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7647 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7633 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7584 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7531 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7485 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7485 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD943 |
Approved |
0.7484 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7472 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7457 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7446 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7414 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7414 |
Intermediate Similarity |
NPD919 |
Approved |
0.7391 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7377 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7349 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7341 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7278 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7256 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7247 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7225 |
Intermediate Similarity |
NPD37 |
Approved |
0.7222 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7219 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD2403 |
Approved |
0.72 |
Intermediate Similarity |
NPD4966 |
Approved |
0.72 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.72 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7191 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7191 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7188 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7178 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7165 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7159 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7127 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7118 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7091 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7065 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7065 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7055 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7048 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7039 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.701 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.6994 |
Remote Similarity |
NPD1653 |
Approved |
0.699 |
Remote Similarity |
NPD7698 |
Approved |
0.699 |
Remote Similarity |
NPD7697 |
Approved |
0.699 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6982 |
Remote Similarity |
NPD4628 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD8434 |
Phase 2 |
0.6962 |
Remote Similarity |
NPD9269 |
Phase 2 |
0.6959 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6957 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6954 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.695 |
Remote Similarity |
NPD7874 |
Approved |
0.695 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6949 |
Remote Similarity |
NPD5353 |
Approved |
0.6936 |
Remote Similarity |
NPD920 |
Approved |
0.6935 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6927 |
Remote Similarity |
NPD6535 |
Approved |
0.6927 |
Remote Similarity |
NPD6534 |
Approved |
0.6923 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6919 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6914 |
Remote Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.691 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.6875 |
Remote Similarity |
NPD5090 |
Approved |
0.6875 |
Remote Similarity |
NPD5089 |
Approved |
0.6868 |
Remote Similarity |
NPD5242 |
Approved |
0.686 |
Remote Similarity |
NPD7907 |
Approved |
0.686 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD3226 |
Approved |
0.6845 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6845 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.6832 |
Remote Similarity |
NPD7801 |
Approved |
0.6829 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD2654 |
Approved |
0.6821 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6821 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.6816 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6813 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6811 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6805 |
Remote Similarity |
NPD2344 |
Approved |
0.6802 |
Remote Similarity |
NPD2493 |
Approved |
0.6802 |
Remote Similarity |
NPD2494 |
Approved |
0.6786 |
Remote Similarity |
NPD3748 |
Approved |
0.6784 |
Remote Similarity |
NPD4582 |
Approved |
0.6784 |
Remote Similarity |
NPD4583 |
Approved |
0.6784 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6768 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6763 |
Remote Similarity |
NPD4665 |
Approved |
0.6747 |
Remote Similarity |
NPD4060 |
Phase 1 |
0.6738 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6734 |
Remote Similarity |
NPD4004 |
Approved |
0.6734 |
Remote Similarity |
NPD4002 |
Approved |
0.6727 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6725 |
Remote Similarity |
NPD1243 |
Approved |
0.6725 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6724 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.672 |
Remote Similarity |
NPD8313 |
Approved |
0.672 |
Remote Similarity |
NPD8312 |
Approved |
0.6717 |
Remote Similarity |
NPD3452 |
Approved |
0.6717 |
Remote Similarity |
NPD3450 |
Approved |
0.6709 |
Remote Similarity |
NPD9268 |
Approved |
0.6707 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6706 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6705 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6702 |
Remote Similarity |
NPD7240 |
Approved |
0.6687 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6686 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6684 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7783 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD2163 |
Approved |
0.6647 |
Remote Similarity |
NPD2309 |
Approved |
0.6627 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6619 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6617 |
Remote Similarity |
NPD8320 |
Phase 1 |
0.6617 |
Remote Similarity |
NPD8319 |
Approved |
0.6614 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6611 |
Remote Similarity |
NPD4585 |
Approved |
0.6609 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6608 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6599 |
Remote Similarity |
NPD2974 |
Approved |
0.6599 |
Remote Similarity |
NPD2973 |
Approved |
0.6599 |
Remote Similarity |
NPD2975 |
Approved |
0.6597 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6592 |
Remote Similarity |
NPD6386 |
Approved |
0.6592 |
Remote Similarity |
NPD6385 |
Approved |
0.6591 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6584 |
Remote Similarity |
NPD3705 |
Approved |
0.6583 |
Remote Similarity |
NPD4580 |
Approved |
0.657 |
Remote Similarity |
NPD2424 |
Discontinued |
0.6557 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6545 |
Remote Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.6543 |
Remote Similarity |
NPD9717 |
Approved |
0.6541 |
Remote Similarity |
NPD9545 |
Approved |
0.6541 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6534
|
Remote Similarity |
NPD3146 |
Approved |